GE HealthCare Technologies (STU:L0T) Beneish M-Score: -2.40 (As of Jun. 27, 2026)


STU:L0T GE HealthCare Technologies Inc STU:L0T
72 GF Score
Price €57.67
GF Value €74.58
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is GE HealthCare Technologies Beneish M-Score?

GE HealthCare Technologies STU:L0T +1.37% 72 Beneish M-Score is -2.40 as of Jun. 27, 2026. GuruFocus rates STU:L0T with a GF Score™ of 72/100 and a GF Value™ of €74.58 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 766 Medical Devices & Instruments companies, GE HealthCare Technologies ranks worse than 64.49% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.4 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for GE HealthCare Technologies's Beneish M-Score or its related term are showing as below:

STU:L0T' s Beneish M-Score Range Over the Past 10 Years
Min: -2.87   Med: -2.53   Max: -2.36
Current: -2.4

During the past 7 years, the highest Beneish M-Score of GE HealthCare Technologies was -2.36. The lowest was -2.87. And the median was -2.53.


GE HealthCare Technologies Beneish M-Score Historical Data

* Premium members only.

The historical data trend for GE HealthCare Technologies's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GE HealthCare Technologies Beneish M-Score Chart

GE HealthCare Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial 0.00 0.00 -2.55 -2.53 -2.39

GE HealthCare Technologies Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.40 -2.42 -2.36 -2.39 -2.40

STU:L0T vs DXCM, STE, ZBH: Beneish M-Score Comparison

For the Medical Devices subindustry, GE HealthCare Technologies's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GE HealthCare Technologies Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, GE HealthCare Technologies's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where GE HealthCare Technologies's Beneish M-Score falls into.


STU:L0T
72GF Score
GE HealthCare Technologies Inc STU:L0T
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GE HealthCare Technologies Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of GE HealthCare Technologies for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0384+0.528 * 1.0729+0.404 * 1.0169+0.892 * 0.9811+0.115 * 1.038
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9508+4.679 * -0.011391-0.327 * 1.0075
=-2.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was €4,099 Mil.
Revenue was 4438.315 + 4866.092 + 4382.688 + 4340.202 = €18,027 Mil.
Gross Profit was 1710.105 + 1930.894 + 1695.48 + 1720.995 = €7,057 Mil.
Total Current Assets was €9,018 Mil.
Total Assets was €32,113 Mil.
Property, Plant and Equipment(Net PPE) was €2,677 Mil.
Depreciation, Depletion and Amortization(DDA) was €511 Mil.
Selling, General, & Admin. Expense(SGA) was €3,697 Mil.
Total Current Liabilities was €7,378 Mil.
Long-Term Debt & Capital Lease Obligation was €9,029 Mil.
Net Income was 336.485 + 503.006 + 379.992 + 421.362 = €1,641 Mil.
Non Operating Income was 75.255 + 63.196 + 76.68 + 57.222 = €272 Mil.
Cash Flow from Operations was 250.85 + 896.7 + 505.236 + 81.498 = €1,734 Mil.
Total Receivables was €4,024 Mil.
Revenue was 4418.725 + 5079.645 + 4381.563 + 4495.431 = €18,375 Mil.
Gross Profit was 1861.1 + 2172.625 + 1824.525 + 1859.858 = €7,718 Mil.
Total Current Assets was €9,005 Mil.
Total Assets was €31,067 Mil.
Property, Plant and Equipment(Net PPE) was €2,637 Mil.
Depreciation, Depletion and Amortization(DDA) was €527 Mil.
Selling, General, & Admin. Expense(SGA) was €3,964 Mil.
Total Current Liabilities was €9,221 Mil.
Long-Term Debt & Capital Lease Obligation was €6,533 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(4099.235 / 18027.297) / (4023.75 / 18375.364)
=0.22739 / 0.218975
=1.0384

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(7718.108 / 18375.364) / (7057.474 / 18027.297)
=0.420025 / 0.391488
=1.0729

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (9018.49 + 2677.175) / 32113.125) / (1 - (9004.875 + 2637.175) / 31067.05)
=0.635798 / 0.625261
=1.0169

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=18027.297 / 18375.364
=0.9811

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(526.764 / (526.764 + 2637.175)) / (511.441 / (511.441 + 2677.175))
=0.16649 / 0.160396
=1.038

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(3697.482 / 18027.297) / (3964.027 / 18375.364)
=0.205105 / 0.215725
=0.9508

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((9028.87 + 7377.585) / 32113.125) / ((6533.275 + 9221.325) / 31067.05)
=0.510896 / 0.507116
=1.0075

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1640.845 - 272.353 - 1734.284) / 32113.125
=-0.011391

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

GE HealthCare Technologies has a M-score of -2.46 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.40 mean?
GE HealthCare Technologies (STU:L0T) has a Beneish M-Score of -2.40 as of Jun. 27, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on GE HealthCare Technologies and its competitors. According to the industry distribution chart, GE HealthCare Technologies ranks #494 out of 766 companies in the Medical Devices & Instruments industry, placing it in the top 64.5%.
Is GE HealthCare Technologies' Beneish M-Score too high?
GE HealthCare Technologies' current Beneish M-Score is -2.40. Based on the distribution chart, GE HealthCare Technologies ranks #494 out of 766 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, GE HealthCare Technologies has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' Beneish M-Score compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #494 out of 766 companies for Beneish M-Score. This places GE HealthCare Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on GE HealthCare Technologies and its competitors. GE HealthCare Technologies's current Beneish M-Score is -2.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (STU:L0T) is currently considered Modestly Undervalued. The stock's GF Value™ is €74.58, compared to a current price of €57.67 — trading 22.7% below its estimated fair value. The current Beneish M-Score is -2.40. GE HealthCare Technologies' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For GE HealthCare Technologies (STU:L0T), the current Beneish M-Score is -2.40 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GE HealthCare Technologies (STU:L0T) Overvalued in 2026?

Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued. The current stock price of €57.67 is trading 22.7% below its estimated GF Value™ of €74.58. GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.

Key valuation signals for STU:L0T:

  • Beneish M-Score: -2.40
  • GF Value™: €74.58 vs. price of €57.67 (22.7% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the STU:L0T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


GE HealthCare Technologies Business Description

Address 500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
72GF Score

Get the complete analysis for STU:L0T

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€57.67
Price
€74.58
GF Value